Wipo Igc Negotiations Indian Participation India.

1. Overview of WIPO IGC

The WIPO Intergovernmental Committee (IGC) is a forum under the World Intellectual Property Organization (WIPO), established in 2000, to address intellectual property (IP) issues related to:

Genetic Resources (GRs) – plants, animals, microorganisms.

Traditional Knowledge (TK) – knowledge systems of indigenous and local communities.

Traditional Cultural Expressions (TCEs) / Folklore – artistic and cultural expressions of communities.

Mandate:

Develop international legal instruments to protect TK, TCEs, and GRs.

Address misappropriation (biopiracy) and ensure benefit-sharing.

Harmonize with CBD (Convention on Biological Diversity) and Nagoya Protocol.

India’s Role:

India is an active participant due to its rich biodiversity and TK heritage.

Advocates defensive protection (preventing misappropriation) and positive protection (rewarding rightful knowledge holders).

Influential in drafting wipo/tk treaties and guidelines.

2. India’s Approach in IGC Negotiations

Defensive Protection

India submits databases like the Traditional Knowledge Digital Library (TKDL) to prevent patenting of Indian traditional knowledge abroad.

Example: Yoga, turmeric, neem, and basmati rice patents were revoked using TKDL evidence.

Positive Protection

India advocates mechanisms for benefit-sharing to ensure communities receive royalties or recognition for their knowledge.

Flexibility in IP Instruments

India pushes for instruments that are compatible with national laws, particularly the Biological Diversity Act, 2002 and the Indian Patents Act, 1970.

3. Key Indian Contributions / Positions in WIPO IGC

(A) Traditional Knowledge Digital Library (TKDL)

Launched by India in 2001, containing Ayurveda, Unani, Siddha, and Yoga knowledge.

Submitted to patent offices worldwide (EPO, USPTO, UKIPO, etc.) as defensive documentation.

Outcome: Numerous patents revoked for lack of novelty using TKDL.

Case Example:

Turmeric Patent (US Patent 5,401,504, 1998)

Claimed “use of turmeric for wound healing.”

TKDL evidence proved prior art.

Patent revoked.

Significance: Demonstrates India’s active defensive use of TKDL, which is central to IGC discussions.

(B) Neem Patent Dispute (Europe & US)

Patent Issue: Patent claimed method of extracting neem oil for pesticidal use.

India’s Intervention: TKDL provided evidence of traditional use of neem in pest control, predating patent claims.

Outcome: EPO revoked the patent in 2000.

Impact: India highlighted biopiracy prevention, influencing IGC discussions on disclosure of origin in patents.

(C) Basmati Rice Patents (US and EU)

US Patent 5,663,484: Claimed a method of producing “Basmati-like rice.”

India’s Submission: TKDL and historical evidence proving prior existence of basmati rice in India.

Outcome: USPTO revoked patent in 2002.

Significance for IGC: India stressed the importance of defensive databases to prevent misappropriation.

(D) IGC Draft Text Negotiations (2001–2023)

India consistently participates in IGC draft treaty negotiations:

Advocates mandatory disclosure of source and origin of genetic resources in patent applications.

Supports mutually agreed terms (MAT) and benefit-sharing obligations.

Proposes flexible sui generis protection for TK/TCEs.

Key Contribution: India’s position influenced the 2016 “Draft Articles on the Protection of TK/TCEs”, emphasizing:

Community rights

Protection against misappropriation

Defensive databases as prior art

(E) Case-Like Interventions (India Using TKDL in IGC-Related Litigation)

Although IGC itself is a negotiation forum, India’s participation connects to domestic and international IP litigation, often cited in WIPO discussions:

US Turmeric Patent (5,401,504) – TKDL evidence prevented biopiracy.

Neem Patent Revocation (US & EP) – TKDL and prior art evidence.

Basmati Rice Patents – TKDL evidence for revocation.

Yoga-related Patents – India submitted TKDL to prevent yoga-related patents in Europe.

Ayurvedic Formulations – TKDL prevented several patents on formulations like “triphala” and “ashwagandha.”

Significance in IGC: These cases are often referenced by India to demonstrate the need for international frameworks protecting TK and TCEs.

(F) India’s Stance on Disclosure of Origin and Benefit Sharing

India pushes for:

Mandatory disclosure of GR/TK source in patents.

Benefit-sharing obligations if patented inventions use TK or GR.

Recognition of community ownership of TK.

These demands are inspired by CBD and Nagoya Protocol principles, and India actively negotiates for binding IGC instruments.

4. Key Principles Emerging from India’s Participation

Defensive Protection is Priority – TKDL prevents wrongful patenting abroad.

Positive Protection via Benefit Sharing – Communities must be rewarded for knowledge use.

Disclosure of Source in Patent Applications – India argues for legal obligation in patents.

Integration with National Laws – IGC treaties should complement Biological Diversity Act, 2002.

Sui Generis Protection for TK/TCE – India advocates a separate IP regime for traditional knowledge.

Active Role in Negotiations – India has consistently been a leading voice among developing countries.

5. Summary Table: India’s Key IGC-Related Interventions and Cases

YearIssue / CaseTKDL / Patent ReferenceOutcome / RelevanceIGC Implication
1997–2000Turmeric patent (US 5,401,504)TKDL used as prior artPatent revokedHighlighted need for defensive protection
2000Neem patent (US/EU)TKDL & prior artPatent revokedStrengthened India’s biopiracy prevention role
2002Basmati rice patents (US/EU)TKDL evidencePatent revokedReinforced prior art protection of TK
2001–2016IGC negotiationsIndia submitted TKDL & draft proposalsDraft articles on TK/TCE protectionAdvocated community rights, benefit-sharing, and disclosure
2010–2015Ayurvedic/Herbal formulationsTKDL submissionsSeveral patents rejectedDemonstrated international applicability of defensive databases
2018–2023Yoga & TCE patentsTKDL submissionsPatents denied or revokedStrengthened India’s position in IGC for TCE protection

6. Conclusion

India’s participation in WIPO IGC is active, strategic, and pioneering:

Defensive protection via TKDL has prevented biopiracy globally.

Positive protection proposals aim to reward communities and integrate benefit-sharing.

India’s legal experience with patent revocations (turmeric, neem, basmati, yoga, ayurvedic formulations) provides practical backing in IGC negotiations.

India is consistently advocating for binding international norms, mandatory disclosure of source, and sui generis TK/TCE regimes.

LEAVE A COMMENT